Treatment of HYP-mice with SPR4 peptide resulted in striking beneficial changes in serum glucose, insulin, leptin, osteocalcin, sclerostin, fat mass, 1.25(OH)2D3, and calcium with a partial correction of the hypophosphatemia. This evidence concerns the gene SOST and X-linked dominant hypophosphatemic rickets.